Literature DB >> 3597773

Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis.

S L Marchesi, J T Letsinger, D W Speicher, V T Marchesi, P Agre, B Hyun, G Gulati.   

Abstract

Two variant spectrins have been described in hereditary elliptocytosis (HE) and pyropoikilocytosis (HPP). Both are characterized by increased susceptibility of the alpha I (N-terminal) 80-kD domain to mild tryptic digestion, yielding peptides of 46-50 or 65-68 kD (T50a and T68 in our terminology). In this report we add a third unstable spectrin alpha I domain found in three kindreds with HE; alpha IT80 in this type of spectrin is cleaved by mild tryptic digestion to a 50-kD peptide (T50b) distinguished from T50a by its more basic isoelectric point. All three spectrins show impaired self-association to form oligomers. Intermediate tryptic peptides of the three unstable alpha I domains from HE spectrins were characterized by monoclonal immunoblotting and I125 limit peptide mapping and affinity purified using polyclonal anti-alpha IT80. Partial amino acid sequences of alpha I domain peptides were obtained from two unrelated patients for each of the three variant spectrins. T50a results from cleavage at arginine 250 or lysine 252 of alpha IT80; a proline replaced the normal leucine or serine at residues 254 and 255, respectively. T50b and a 19-kD peptide result from cleavage at arginine 462 or arginine 464; a proline replaced the normal residue 465 (in T19b) in one of the two patients studied. T68 results from cleavage at arginine 131. In both 68-kD peptides examined, a leucine is inserted at residue 150. The relationship of the sequence changes to the new tryptic cleavages, to the current model of alpha I domain structure, and to defective spectrin self-association is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597773      PMCID: PMC442218          DOI: 10.1172/JCI113047

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Common structural polymorphisms in human erythrocyte spectrin.

Authors:  W J Knowles; M L Bologna; J A Chasis; S L Marchesi; V T Marchesi
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

2.  Isolation of the chemical domains of human erythrocyte spectrin.

Authors:  W J Knowles; M L Bologna
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Structure of human erythrocyte spectrin. II. The sequence of the alpha-I domain.

Authors:  D W Speicher; G Davis; V T Marchesi
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

4.  Structure of human erythrocyte spectrin. I. Isolation of the alpha-I domain and its cyanogen bromide peptides.

Authors:  D W Speicher; G Davis; P D Yurchenco; V T Marchesi
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

5.  Molecular heterogeneity of hereditary pyropoikilocytosis: identification of a second variant of the spectrin alpha-subunit.

Authors:  J Lawler; J Palek; S C Liu; J Prchal; W M Butler
Journal:  Blood       Date:  1983-12       Impact factor: 22.113

6.  Identification of the hereditary pyropoikilocytosis carrier state.

Authors:  W C Mentzer; T Turetsky; N Mohandas; S Schrier; C S Wu; H Koenig
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  Identification of functional domains of human erythrocyte spectrin.

Authors:  J S Morrow; D W Speicher; W J Knowles; C J Hsu; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  A molecular defect of spectrin in a subset of patients with hereditary elliptocytosis. Alterations in the alpha-subunit domain involved in spectrin self-association.

Authors:  J Lawler; S C Liu; J Palek; J Prchal
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Synthesis and assembly of spectrin during avian erythropoiesis: stoichiometric assembly but unequal synthesis of alpha and beta spectrin.

Authors:  I Blikstad; W J Nelson; R T Moon; E Lazarides
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

10.  Molecular and functional changes in spectrin from patients with hereditary pyropoikilocytosis.

Authors:  W J Knowles; J S Morrow; D W Speicher; H S Zarkowsky; N Mohandas; W C Mentzer; S B Shohet; V T Marchesi
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  23 in total

1.  Alpha I/65 hereditary elliptocytosis in southern Italy: evidence for an African origin.

Authors:  E M del Giudice; M T Ducluzeau; N Alloisio; R Wilmotte; J Delaunay; S Perrotta; S Cutillo; A Iolascon
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

2.  Evidence that expression of Sp alpha I/65 hereditary elliptocytosis is compounded by a genetic factor that is linked to the homologous alpha-spectrin allele.

Authors:  D Guetarni; A F Roux; N Alloisio; F Morlé; M T Ducluzeau; B G Forget; P Colonna; J Delaunay; J Godet
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

3.  Pathogenic proline mutation in the linker between spectrin repeats: disease caused by spectrin unfolding.

Authors:  Colin P Johnson; Massimiliano Gaetani; Vanessa Ortiz; Nishant Bhasin; Sandy Harper; Patrick G Gallagher; David W Speicher; Dennis E Discher
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

4.  Spectrin folding versus unfolding reactions and RBC membrane stiffness.

Authors:  Qiang Zhu; Robert J Asaro
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

5.  The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasion.

Authors:  Xinhong Pei; Xinhua Guo; Ross Coppel; Souvik Bhattacharjee; Kasturi Haldar; Walter Gratzer; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2007-04-27       Impact factor: 22.113

6.  Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).

Authors:  L Morlé; A F Roux; N Alloisio; B Pothier; J Starck; L Denoroy; F Morlé; R C Rudigoz; B G Forget; J Delaunay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

7.  Probing large conformational rearrangements in wild-type and mutant spectrin using structural mass spectrometry.

Authors:  Sira Sriswasdi; Sandra L Harper; Hsin-Yao Tang; Patrick G Gallagher; David W Speicher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

8.  Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.

Authors:  T L Coetzer; K Sahr; J Prchal; H Blacklock; L Peterson; R Koler; J Doyle; J Manaster; J Palek
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.

Authors:  Santhi K Ganesh; Neil A Zakai; Frank J A van Rooij; Nicole Soranzo; Albert V Smith; Michael A Nalls; Ming-Huei Chen; Anna Kottgen; Nicole L Glazer; Abbas Dehghan; Brigitte Kuhnel; Thor Aspelund; Qiong Yang; Toshiko Tanaka; Andrew Jaffe; Joshua C M Bis; Germaine C Verwoert; Alexander Teumer; Caroline S Fox; Jack M Guralnik; Georg B Ehret; Kenneth Rice; Janine F Felix; Augusto Rendon; Gudny Eiriksdottir; Daniel Levy; Kushang V Patel; Eric Boerwinkle; Jerome I Rotter; Albert Hofman; Jennifer G Sambrook; Dena G Hernandez; Gang Zheng; Stefania Bandinelli; Andrew B Singleton; Josef Coresh; Thomas Lumley; André G Uitterlinden; Janine M Vangils; Lenore J Launer; L Adrienne Cupples; Ben A Oostra; Jaap-Jan Zwaginga; Willem H Ouwehand; Swee-Lay Thein; Christa Meisinger; Panos Deloukas; Matthias Nauck; Tim D Spector; Christian Gieger; Vilmundur Gudnason; Cornelia M van Duijn; Bruce M Psaty; Luigi Ferrucci; Aravinda Chakravarti; Andreas Greinacher; Christopher J O'Donnell; Jacqueline C M Witteman; Susan Furth; Mary Cushman; Tamara B Harris; Jing-Ping Lin
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.